Navigation Links
Ceregene Presents Long Term Follow-Up Data From Phase 1 Trial of,CERE-120 Demonstrating Improved Motor Function in Parkinson's,Patients

dopamine-producing nerve cells exhibit the progressive inability to initiate and control physical movements. There is currently no cure for Parkinson's disease.

About Ceregene

Ceregene, Inc. is a San Diego-based biotechnology company focused on the development of gene therapies for neurodegenerative disorders. Ceregene is in the clinic with CERE-110, an AAV2 based vector expressing nerve growth factor that is being tested as a treatment for Alzheimer's disease, and with CERE-120 for Parkinson's disease. CERE-130 is in late preclinical development for ALS. Ceregene was launched in January 2001 and is a former subsidiary of Cell Genesys, Inc. , which is headquartered in South San Francisco, CA. Ceregene's investors include Alta Partners, MPM Capital, Investor Growth Capital and Cell Genesys, as well as Hamilton BioVentures and, California Technology Partners.

About The Michael J. Fox Foundation

Founded in 2000, The Michael J. Fox Foundation for Parkinson's Research is dedicated to ensuring the development of a cure for Parkinson's disease within this decade through an aggressively funded research agenda. The Foundation has funded more than $90 million in research to date, either directly or through partnerships.

CONTACT: Jeffrey M. Ostrove, Ph.D., President and CEO of Ceregene, Inc.,+1-858-458-8808

Web site: http://www.ceregene.com/

Ticker Symbol: (NASDAQ-NMS:CEGE)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3 4

Related medicine technology :

1. Ceregene Presents Interim Phase 1 Clinical Data of CERE-110 for the Treatment of Alzheimers Disease
2. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
3. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
4. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
5. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
6. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
7. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
8. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
9. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
10. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
11. DiObex Presents Phase 2a Data of DIO-902 Demonstrating Trends of Improved Glycemic Control and Significant Reductions of LDL-Cholesterol and C-Reactive Protein
Post Your Comments:
(Date:9/23/2014)... Sept. 23, 2014 The Pennsylvania State Police will ... 27, as part of National Prescription Drug Take-Back Day. ... Take-Back Day is a national initiative, conducted ... aimed at encouraging the public to dispose of expired, ... abuse and theft. From 10 a.m. to ...
(Date:9/23/2014)... AVIV, Israel , Sept. 23, 2014 /PRNewswire/ ... ) ("Galmed"), a clinical-stage biopharmaceutical company focused on ... therapy for the treatment of liver diseases and ... and Drug Administration, or the FDA, approved its ... candidate, aramchol, for the treatment of Non-Alcoholic Steato-Hepatitis, ...
(Date:9/23/2014)...  Vesselon, Inc. today announced the appointment of Jurgen ... 15, 2014. Dr. Raths, appointment follows Vesselon,s engagement with ... market a private preferred Series A round to facilitate ... "Jurgen,s deep experience across multiple functional areas of ... Vesselon as we develop our device that can be ...
Breaking Medicine Technology:Galmed Pharmaceuticals Announces U.S. FDA Approval of Fast Track Designation of Aramchol for the Treatment of NASH 2Galmed Pharmaceuticals Announces U.S. FDA Approval of Fast Track Designation of Aramchol for the Treatment of NASH 3Vesselon Announces Jurgen Raths, MD to Serve on Board of Directors 2Vesselon Announces Jurgen Raths, MD to Serve on Board of Directors 3
... (NYSE: DGX ), the world,s leading provider of ... of Directors declared a quarterly cash dividend of $0.17 per ... of Quest Diagnostics common stock on April 3, 2012. ... is the world,s leading provider of diagnostic testing, information and ...
... For the first time, consumers shopping for over-the-counter ... system that appears on the skin, affecting as ... joint and tendon disease—will find a National Psoriasis ... experts deem effective in relieving disease symptoms. Learn ...
Cached Medicine Technology:National Psoriasis Foundation Launches "Seal of Recognition" for Psoriasis Products 2National Psoriasis Foundation Launches "Seal of Recognition" for Psoriasis Products 3
(Date:9/23/2014)... By Karen Pallarito ... -- Imagine if doctors and hospitals got paid for providing ... consumers had better data for making informed health choices. ... health system is headed. The report, from the IMS ... of change" -- recent events expected to alter the delivery ...
(Date:9/23/2014)... 23, 2014 What information do ... National Quality Forum (NQF) released a report ( ... and an infographic ( http://bit.ly/1tX3lzA ) resulting from ... healthcare, how patients define affordability, and what information ... the best possible healthcare at the lowest possible ...
(Date:9/23/2014)... recent Oregon survey about an exercise DVD that adds ... of elementary school students found it had a high ... offered clear advantages for overly sedentary educational programs. , ... by the Healthy Youth Program of the Linus Pauling ... , Brain Breaks leads children in 5-7 minute segments ...
(Date:9/23/2014)... California (PRWEB) September 23, 2014 ... Oracle services market. Included are Oracle Managed ... Augmentation. Trevera supports all versions of Oracle E-Business ... point releases. , Trevera has announced a ... organizations that need help with their software technology ...
(Date:9/23/2014)... September 23, 2014 Risperdal lawsuits ( ... the country, Bernstein Liebhard LLP reports. According to an ... Florida on September 19th, the Court has dismissed fraud ... in that jurisdiction on behalf of a man who ... due to his use of Risperdal. In dismissing the ...
Breaking Medicine News(10 mins):Health News:Report Identifies Game Changers for U.S. Health Care 2Health News:Report Identifies Game Changers for U.S. Health Care 3Health News:Finding Affordable Care: Asking the Right Question is Key 2Health News:'Brain Breaks' increase activity, educational performance in elementary schools 2Health News:'Brain Breaks' increase activity, educational performance in elementary schools 3Health News:Trevera, Inc adds Management Support to Services 2Health News:Trevera, Inc adds Management Support to Services 3Health News:Risperdal Lawsuit News: Fraud, Negligence Per Se Claims Dismissed from Florida Complaint, Bernstein Liebhard LLP Reports 2Health News:Risperdal Lawsuit News: Fraud, Negligence Per Se Claims Dismissed from Florida Complaint, Bernstein Liebhard LLP Reports 3
... be the greatest advance in waking up since coffee, ... wake up,in the morning feeling refreshed and ready to go, ... performance to spousal,relations and even driving ability. Fortunately, a unique ... a pill you take before,bedtime that will help you to ...
... specialty bio-therapeutics company developing high-value human,therapeutic proteins for commercialization, will hold its Annual ... Wednesday, April 9, 2008, Time: ... The National Club ... Toronto, Ontario Mr. ...
... look in your,medicine cabinet -- do you spot ... the nation,s dramatic increase in irresponsible,prescription drug use? ... 71 percent of prescription pain medication abusers,obtained the ... 13-year-olds,prescription drug abuse actually exceeds marijuana use., ...
... Awareness ... Month, PRINCETON, N.J., April 8, ... U.S. raising,awareness regarding the poor state of sexual health in America and urging,Americans ... and the Evolve tour is designed to address this head on by,inspiring a ...
... The appearance of a cold sore is,a sign that ... serious,illnesses emerge, according to John Sherman, ND, noted naturopathic,physician ... between 80% and 90% of the adult population have ... to Dr. Sherman, who,is the author of The Complete ...
... Moses and his,wife Ida thought they were doing everything ... multiple medical problems, Moses had an ugly,uncomfortable sore on ... go,away., Dr. Harris Greenberger, Director of Sound Foot ... and Stamford Hospitals in,Connecticut, diagnosed it as a diabetic ...
Cached Medicine News:Health News:Tired Mother Invents Pill to Wake You Up On Time 2Health News:Media Invitation - Annual General and Special Meeting of Shareholders of Haemacure 2Health News:Prescription Drug Abuse Threatens Availability of Pain Medication 2Health News:Video: Rubber Hits the Road as Trojan(R) Campaigns for Sexual Health in America to Evolve 2Health News:Video: Rubber Hits the Road as Trojan(R) Campaigns for Sexual Health in America to Evolve 3Health News:A Cold Sore Is Often A Warning Sign of Deeper Health Issues, Expert Says 2Health News:Living Cell Treatment Heals Diabetic Foot Sores Fast 2
Solid steel construction for lifelong quality. Strong, smooth and quiet electro-mechanical up/down movement. Dual castor, locking wheels for use on carpet or tile flooring. Easy cleaning, deluxe lami...
Trial lens set +/- Cyl....
... Contemporary Soft Touch control panel with ... Pebble Gray, Noir Black, Colonial Blue and ... arms. Durable cast iron and steel construction ... smooth, quiet and reliable up/down chair movement. ...
Our Ophthalmic Diagnostic Sets offer everything an eye care specialist needs. Complete your set with your choice of ophthalmoscope, retinoscope, handle, and case....
Medicine Products: